Centre Hospitalier Intercommunal Creteil — Clinical Trial Site

167 Registered trials

85 Currently recruiting

Organisation

Centre Hospitalier Intercommunal Creteil

Location

Creteil, France

Identifier

ORG-100042860

Address

40 Avenue De Verdun, 94010, France

Departments

#2303:Service de Pédiatrie
2304:Service de Pneumologie
250005: Service Ophtalmologie
3205: Ophtalmology
94000
94010
CHI Créteil - Pneumologie
Consultation pediatrique
Creteil CHIC (enfants)
Département de Pneumologie
DERMATOLOGIE
Dermatology
Dermatology department
FRA009: Centre de Coordination en Cancérologie
gastroenterology
gynecology
hépatogastroentérologie
Hepatogastroenterology
INFECTIOLOGY
Intensive care
Internal medecine
Internal Medicine
Maladies infectieuses et Tropicales
Maternité
Médecine interne
Medical onclogy
Medical oncology
N/A
Néonatologie
Neonatology
Obstetric gynecology
Obstetrics
ONCOLOGIE
ONCOLOGIE MEDICALE
Oncologie-Radiothérapie
oncology
Oncology-Radiotherapy
Ophtalmologie
Ophtalmology
Ophthalmology
Ophthalmology Department
Orthopédie
Paediatrics
Pédiatrie
Pédiatrie Générale
PMA
Pneumologie
Pneumologie / UFR Sante Medecine
Pneumologie Batiment U
Pneumologie Oncologie thoracique
Pneumology
Pneumology and Thoracic Oncology
Pneumology department
Public health and Social Medicine
Pulmonology
Radiothérapie
Radiotherapy
Radiotherapy -Oncology
Réanimation médicale
Service d'Hepato-Gastro-Enterologie
Service d'Hépatologie
Service d'Ophtalomologie
Service d’ophtalmologie
Service de gastroentérologie et hépatologie
Service de gynécologie obstétrique, - unité de médecine de la reproduction
Service de Médecine Interne
Service de Pediatrie
Service de pédiatrie - Hôpital de jour
Service de Pneumologie
Service de pneumologie; Service de pédiatrie
Service Hepato-gastroenterologie
Service Ophtalmologie
Service Pédiatrie - Reference centres for SCD
Service Pneumologie
Service pneumology
Urgences pédiatriques

Clinical trials at this site (167)

Search interface

Effect of long-term carvedilol to prevent decompensation or death in patients with asymptomatic Child-Pugh A5 to B8 cirrhosis and clinically… Recruiting

2024-511663-28-00 Asymptomatic Child-Pugh A5 to B8 cirrhosis 6 2025-09-11
A study to evaluate the efficacy and safety of ruxolitinib cream in children (6 to <12 years old) with non-segmental vitiligo Recruiting

2024-513171-41-00 Vitiligo 5 2025-09-11
TOCIACS : Efficacy and safety of Tocilizumab for acute chest syndrome treatment in paediatric and adult patients with sickle cell disease Recruiting

2023-505109-17-00 Sickle cell disease 5 2025-08-27
Study of Daraxonrasib (RMC-6236) in Patients with RAS Mutated NSCLC Recruiting

2024-518154-16-00 non-small cell lung cancer 5 2025-08-27
Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department Recruiting

2023-504847-15-00 vaso-occlusive crisis due to sickle cell disease 5 2025-07-21
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer Recruiting

2024-515884-69-00 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 5 2025-07-16
Efficacy of methylprednisolone pulses in neuroendocrine cells hyperplasia of infancy: an early phase study (CORTICONEHI). Recruiting

2023-508132-65-00 NEUROENDOCRINE CELLS HYPERPLASIA OF INFANCY 4 2025-06-30
Evaluating ivonescimab as a potential treatment for pleural mesothelioma patients whose cancer has returned after previous immunotherapy and… Recruiting

2024-519052-82-00 pleural mesothelioma 4 2025-06-30
Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting

2024-515764-31-00 Non-small cell lung cancer 10 2025-06-13
Dose Range Finding Study to Access Efficacy and Safety of Tozorakimab in Adults with Uncontrolled Asthma on Medium-to-High Dose Inhaled Cort… Recruiting

2024-519116-14-00 Asthma 4 2025-05-27
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 … Recruiting

2023-508634-34-00 co-infected with the HIV-1 and HBV viruses 4 2025-05-14
Corticodependent or corticoresistant brain radionecrosis after radiotherapy for brain metastases: a multicentre randomized, controlled doub… Recruiting

2024-510893-25-00 Brain metastases of cancer > brain radionecrosis 5 2025-04-29
A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinoph… Recruiting

2024-515162-13-00 Eosinophilic Asthma 5 2025-04-29
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chem… Recruiting

2023-505773-32-00 Untreated Metastatic Non-Squamous Non-Small Cell Lung C 10 2025-03-25
First-line immunotherapy-based standard of care and local ablative treatments for oligometastatic non-small cell lung cancer patients: a ran… Recruiting

2023-503326-39-00 Synchronous oligometastatic non-small cell lung cancer 5 2025-03-06
Portal hypertension in cirrhosis Recruiting

2023-508535-32-00 Portal hypertension (PHT) and consequences in complicat 4 2025-03-04
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting

2024-512113-41-00 Severe Asthma 5 2024-11-20
Acute non-severe osteomyelitis in children Recruiting

2024-516744-26-00 acute osteomyelitis of the child 4 2024-11-15
A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Can… Recruiting

2023-509340-10-00 Patients with HLA-A2 positive phenotype and metastatic 5 2024-10-29
QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary s… Recruiting

2024-516101-23-00 Sarcoidosis 5 2024-10-28
A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc… Recruiting

2024-511319-91-00 Advanced non-small cell lung cancer with HER2 (ERBB2) m 5 2024-10-23
Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis Recruiting

2023-504755-26-00 Bronchiectasis 4 2024-10-21
OPEN-LABEL PHASE II EFFICACY STUDY OF REPOTRECTINIB IN FRAIL (PS ≥2) AND /OR ELDERLYPATIENTS WITH ROS1-REARRANGED ADVANCED NSCLC Recruiting

2023-509073-23-00 Stage III/IV non-small-cell lung cancer (NSCLC) harbori 4 2024-10-01